Abstract
As a result of widespread serum prostate-specific antigen (PSA) screening and prostate cancer awareness, the detection of low-grade prostate cancer has increased. At the moment, it is unclear how to treat patients in this population. Thus, we focused on reviewing therapies for patients in this low risk group. The purpose of this review paper is to present the status of emerging therapies of cryotherapy and high-intensity focused ultrasound (HIFU) in patients with low risk disease. Based on our review of the literature, there are several small-scale studies of these two therapies that have revealed favorable outcomes, but with complications of urinary incontinence and impotence. With further research, these therapies may develop into good alternatives for patients in this expanding group.
Keywords: Active Surveillance, Cryotherapy, Focal Therapy, HIFU, Prostate cancer, PSA
Reviews on Recent Clinical Trials
Title: The Current Status of Cryotherapy and High-Intensity Focused UltraSound in the Treatment of Low-Grade Prostate Cancer
Volume: 6 Issue: 2
Author(s): Vassilis J. Siomos and Al Barqawi
Affiliation:
Keywords: Active Surveillance, Cryotherapy, Focal Therapy, HIFU, Prostate cancer, PSA
Abstract: As a result of widespread serum prostate-specific antigen (PSA) screening and prostate cancer awareness, the detection of low-grade prostate cancer has increased. At the moment, it is unclear how to treat patients in this population. Thus, we focused on reviewing therapies for patients in this low risk group. The purpose of this review paper is to present the status of emerging therapies of cryotherapy and high-intensity focused ultrasound (HIFU) in patients with low risk disease. Based on our review of the literature, there are several small-scale studies of these two therapies that have revealed favorable outcomes, but with complications of urinary incontinence and impotence. With further research, these therapies may develop into good alternatives for patients in this expanding group.
Export Options
About this article
Cite this article as:
J. Siomos Vassilis and Barqawi Al, The Current Status of Cryotherapy and High-Intensity Focused UltraSound in the Treatment of Low-Grade Prostate Cancer, Reviews on Recent Clinical Trials 2011; 6 (2) . https://dx.doi.org/10.2174/157488711795177840
DOI https://dx.doi.org/10.2174/157488711795177840 |
Print ISSN 1574-8871 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-1038 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Epigenetic Regulation of EMT: The Snail Story
Current Pharmaceutical Design Active Surveillance for Prostate Cancer and Small Renal Masses: New Evidences and Criticisms
Anti-Cancer Agents in Medicinal Chemistry Soy Isoflavones and Exercise: Possible Benefits for Postmenopausal Womens Cardiovascular Health
Current Women`s Health Reviews Inhibitory Effects of Cathepsin K Inhibitor (ODN-MK-0822) on the Paracrine Pro-Osteoclast Factors of Breast Cancer Cells
Current Molecular Pharmacology Blending of Polyethylenimine with a Cationic Polyurethane Greatly Enhances Both DNA Delivery Efficacy and Reduces the Overall Cytotoxicity
Current Pharmaceutical Biotechnology A Review Exploring Therapeutic Worth of 1,3,4-Oxadiazole Tailored Compounds
Mini-Reviews in Medicinal Chemistry Kinase Phosphorylation-based Mechanisms of PARP Inhibitor Resistance During Synthetic Lethal Oncotherapy
Current Signal Transduction Therapy Roles of Epithelial-Mesenchymal Transition in Cancer Drug Resistance
Current Cancer Drug Targets Synthetic Lethality to Overcome Cancer Drug Resistance
Current Medicinal Chemistry Potential Deployment of Angiotensin I Converting Enzyme Inhibitors and of Angiotensin II Type 1 and Type 2 Receptor Blockers in Cancer Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry MRP1-dependent Collateral Sensitivity of Multidrug-resistant Cancer Cells: Identifying Selective Modulators Inducing Cellular Glutathione Depletion
Current Medicinal Chemistry The Place of Somatostatin Analogs in the Diagnosis and Treatment of the Neuoroendocrine Glands Tumors
Recent Patents on Anti-Cancer Drug Discovery Xanthohumol, a Prenylated Chalcone Derived from Hops, Suppresses Cancer Cell Invasion through Inhibiting the Expression of CXCR4 Chemokine Receptor
Current Molecular Medicine Contemporary Review of Drugs Used to Treat Obesity
Cardiovascular & Hematological Agents in Medicinal Chemistry Combined Anticancer Therapies: An Overview of the Latest Applications
Anti-Cancer Agents in Medicinal Chemistry Experimental Drugs for Neuropathic Pain
Current Neuropharmacology Clear Cell Renal Cell Cancer Tumor-Propagating Cells: Molecular Characteristics
Current Signal Transduction Therapy Clinical Pharmacology of Non-Steroidal Anti-Inflammatory Drugs: A Review
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Phytosynthesized Nanoparticles for Effective Cancer Treatment: A Review
Nanoscience & Nanotechnology-Asia Design, Synthesis and Biological Evaluation of Thiohydantoin Derivatives as Novel Anti-prostate Cancer Agents
Anti-Cancer Agents in Medicinal Chemistry